Triggering Immune System With Nanomaterials for Cancer Immunotherapy
Cancer is a major cause of incidence rate and mortality worldwide. In recent years, cancer immunotherapy has made great progress in the preclinical and clinical treatment of advanced malignant tumors. However, cancer patients will have transient cancer suppression reaction and serious immune related...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2022-04-01
|
| Col·lecció: | Frontiers in Bioengineering and Biotechnology |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/articles/10.3389/fbioe.2022.878524/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|